Cargando…
Genetic variation in DPP-IV gene linked to predisposition of T2DM: A case control study
PURPOSE: DPP-IV is a ubiquitously expressed cell surface protein that can be presented in soluble forms. It has recently gained medical importance as its inhibitors are widely being used as treatment of T2DM. The present research aims to resolve whether genetic variants of DPP-IV have association wi...
Autores principales: | Bhargave, Archna, Devi, Kiran, Ahmad, Imteyaz, Yadav, Anita, Gupta, Ranjan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554862/ https://www.ncbi.nlm.nih.gov/pubmed/36249912 http://dx.doi.org/10.1007/s40200-022-01131-y |
Ejemplares similares
-
Effect of DPP-IV Inhibitors on Glycemic Variability in Patients with T2DM: A Systematic Review and Meta-Analysis
por: Lee, Subin, et al.
Publicado: (2019) -
Effect of DPP-4 inhibitor on elderly patients with T2DM combined with MCI
por: Xue, Jujun, et al.
Publicado: (2020) -
Downregulation of Signaling-active IGF-1 by Dipeptidyl Peptidase IV (DPP-IV)
por: Lin, Ching-Ting, et al.
Publicado: (2010) -
Practical strategies for improving outcomes in T2DM: The potential role of pioglitazone and DPP4 inhibitors
por: Del Prato, Stefano, et al.
Publicado: (2017) -
DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature
por: Saini, Kunika, et al.
Publicado: (2023)